206 related articles for article (PubMed ID: 29146246)
1. Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.
Mastria EM; Cai LY; Kan MJ; Li X; Schaal JL; Fiering S; Gunn MD; Dewhirst MW; Nair SK; Chilkoti A
J Control Release; 2018 Jan; 269():364-373. PubMed ID: 29146246
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
3. Primary tumor and pre-metastatic niches co-targeting "peptides-lego" hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment.
Xiong H; Du S; Zhang P; Jiang Z; Zhou J; Yao J
Biomater Sci; 2018 Sep; 6(10):2591-2604. PubMed ID: 30187035
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma.
Mastria EM; Chen M; McDaniel JR; Li X; Hyun J; Dewhirst MW; Chilkoti A
J Control Release; 2015 Jun; 208():52-8. PubMed ID: 25637704
[TBL] [Abstract][Full Text] [Related]
5. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
6. Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in
Dodd RD; Scherer A; Huang W; McGivney GR; Gutierrez WR; Laverty EA; Ashcraft KA; Stephens VR; Yousefpour P; Saha S; Knepper-Adrian V; Floyd W; Chen M; Ma Y; Mastria EM; Cardona DM; Eward WC; Chilkoti A; Kirsch DG
Clin Cancer Res; 2020 Sep; 26(18):5036-5047. PubMed ID: 32718998
[TBL] [Abstract][Full Text] [Related]
7. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
8. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
[TBL] [Abstract][Full Text] [Related]
9. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy.
Pramanik D; Campbell NR; Das S; Gupta S; Chenna V; Bisht S; Sysa-Shah P; Bedja D; Karikari C; Steenbergen C; Gabrielson KL; Maitra A; Maitra A
Oncotarget; 2012 Jun; 3(6):640-50. PubMed ID: 22791660
[TBL] [Abstract][Full Text] [Related]
10. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
[TBL] [Abstract][Full Text] [Related]
12. Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity.
Amini MA; Abbasi AZ; Cai P; Lip H; Gordijo CR; Li J; Chen B; Zhang L; Rauth AM; Wu XY
J Natl Cancer Inst; 2019 Apr; 111(4):399-408. PubMed ID: 30239773
[TBL] [Abstract][Full Text] [Related]
13. Three steps to breaking immune tolerance to lymphoma: a microparticle approach.
Makkouk A; Joshi VB; Lemke CD; Wongrakpanich A; Olivier AK; Blackwell SE; Salem AK; Weiner GJ
Cancer Immunol Res; 2015 Apr; 3(4):389-98. PubMed ID: 25627654
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.
Mattarollo SR; Loi S; Duret H; Ma Y; Zitvogel L; Smyth MJ
Cancer Res; 2011 Jul; 71(14):4809-20. PubMed ID: 21646474
[TBL] [Abstract][Full Text] [Related]
15. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
Arabi L; Badiee A; Mosaffa F; Jaafari MR
J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
[TBL] [Abstract][Full Text] [Related]
17. Mn
Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J
Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854
[TBL] [Abstract][Full Text] [Related]
18. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection.
MacKay JA; Chen M; McDaniel JR; Liu W; Simnick AJ; Chilkoti A
Nat Mater; 2009 Dec; 8(12):993-9. PubMed ID: 19898461
[TBL] [Abstract][Full Text] [Related]
20. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
